A Novel Imidazopyridine Derivative Exhibits Anticancer Activity in Breast Cancer by Inhibiting Wnt/β‑catenin Signaling

BACKGROUND: Breast cancer exhibits poor prognosis and high relapse rates following chemotherapy therapeutics. Thus, this study aims to develop effective novel agents regulating the core molecular pathway of breast cancer such as Wnt/β-catenin signaling. METHODS: The present study screened a novel in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Onco Targets Ther
Egile Nagusiak: He, Liu-Jun, Yang, Dong-Lin, Chen, He-Ying, Huang, Jiu-Hong, Zhang, Ya-Jun, Qin, Hong-Xia, Wang, Juan-Li, Tang, Dian-Yong, Chen, Zhong-Zhu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553630/
https://ncbi.nlm.nih.gov/pubmed/33116593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S266752
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak